FSPTX | SGTRX | FSPTX / SGTRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 44 years | 22 years | - |
Gain YTD | 1.112 | 3.371 | 33% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.1B | 2.58B | 664% |
Annual Yield % from dividends | 0.01 | 0.00 | - |
Returns for 1 year | 28.06 | 13.96 | 201% |
Returns for 3 years | 40.79 | 7.73 | 528% |
Returns for 5 years | 76.25 | 54.45 | 140% |
Returns for 10 years | 233.34 | 154.97 | 151% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EGOCX | 17.63 | 0.15 | +0.86% |
Allspring Large Cap Core C | |||
JEMOX | 30.84 | 0.17 | +0.55% |
JPMorgan Emerging Markets Equity R5 | |||
BEOIX | 8.21 | N/A | N/A |
Barrow Hanley Concentrated EM ESG Opps I | |||
ARIIX | 9.97 | -0.02 | -0.20% |
AB Global Real Estate Investment II I | |||
PHLQX | 43.75 | -0.45 | -1.02% |
PGIM Jennison Health Sciences R6 |